Literature DB >> 15508527

Cystatin C vs creatinine as markers of renal function in patients on digoxin treatment.

Pär Hallberg1, Håkan Melhus, Lars-Olof Hansson, Anders Larsson.   

Abstract

BACKGROUND: The kidney function is a major determinant of the serum concentration of digoxin as this drug is mainly eliminated unchanged through the kidneys. Since digoxin is widely prescribed among the elderly, and the glomerular filtration rate (GFR) declines with age, it is important that the clinician takes the patient's GFR into account when prescribing digoxin. Serum cystatin C has been suggested to be superior to creatinine for estimation of GFR, which may have relevance for the optimization of treatment with digoxin.
METHODS: To evaluate which of the two GFR markers serum creatinine and serum cystatin C that best correlates with serum digoxin, we compared the serum levels of digoxin with the serum levels of creatinine and cystatin C in 149 patients on therapeutic drug monitoring of digoxin at our hospital.
RESULTS: Overall, there was a stronger correlation between serum digoxin concentrations and cystatin C (p=0.00001) as compared to creatinine (p= 0.00003). Interestingly, of the patients with a serum digoxin concentration > or = 1.5 nmol/L, 29% had a serum creatinine level within normal limits, as compared to 20% with normal cystatin C levels.
CONCLUSIONS: In this study, serum cystatin C correlated better to serum digoxin than did serum creatinine. With improved GFR monitoring, digoxin concentrations should be better controlled.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15508527     DOI: 10.3109/2000-1967-087

Source DB:  PubMed          Journal:  Ups J Med Sci        ISSN: 0300-9734            Impact factor:   2.384


  7 in total

1.  Comparison of estimated creatinine clearance among five formulae (Cockroft-Gault, Jelliffe, Sanaka, simplified 4-variable MDRD and DAF) and the 24hours-urine-collection creatinine clearance.

Authors:  A Diamandopoulos; P Goudas; A Arvanitis
Journal:  Hippokratia       Date:  2010-04       Impact factor: 0.471

2.  A population pharmacokinetic model for cefuroxime using cystatin C as a marker of renal function.

Authors:  Anders Viberg; Anders Lannergård; Anders Larsson; Otto Cars; Mats O Karlsson; Marie Sandström
Journal:  Br J Clin Pharmacol       Date:  2006-09       Impact factor: 4.335

Review 3.  Cystatin C as a potential biomarker for dosing of renally excreted drugs.

Authors:  Nguessan Aimé Brou; Evelyne Jacqz-Aigrain; Wei Zhao
Journal:  Br J Clin Pharmacol       Date:  2015-05-28       Impact factor: 4.335

4.  Regional variation in use of exogenous and endogenous glomerular filtration rate (GFR) markers in Sweden.

Authors:  Susanne Vilhelmsdotter Allander; Lars-Åke Marké; Björn Wihlen; Maria Svensson; Carl-Gustaf Elinder; Anders Larsson
Journal:  Ups J Med Sci       Date:  2012-03-08       Impact factor: 2.384

5.  Serum cystatin C levels to predict serum concentration of digoxin in Japanese patients.

Authors:  Tsutomu Nakamura; Takeshi Ioroi; Toshiyuki Sakaeda; Masanori Horinouchi; Nobuhide Hayashi; Kensuke Saito; Mitsuro Kosaka; Noboru Okamura; Keiichi Kadoyama; Shunichi Kumagai; Katsuhiko Okumura
Journal:  Int J Med Sci       Date:  2006-05-17       Impact factor: 3.738

6.  Cystatin C may be better than creatinine for digoxin dosing in older adults with atrial fibrillation.

Authors:  Tomáš Šálek; Martin Vodička; Martin Gřiva
Journal:  J Clin Lab Anal       Date:  2020-06-17       Impact factor: 2.352

7.  Augmented renal clearance implies a need for increased amoxicillin-clavulanic acid dosing in critically ill children.

Authors:  Pieter A J G De Cock; Joseph F Standing; Charlotte I S Barker; Annick de Jaeger; Evelyn Dhont; Mieke Carlier; Alain G Verstraete; Joris R Delanghe; Hugo Robays; Peter De Paepe
Journal:  Antimicrob Agents Chemother       Date:  2015-09-08       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.